Detalles de la búsqueda
1.
Cedirogant in adults with psoriasis: a phase 2, randomized, placebo-controlled clinical trial.
Clin Exp Dermatol
; 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38699939
2.
Pharmacokinetics, Safety, and Tolerability of Cedirogant in Healthy Japanese and Chinese Adults.
Clin Pharmacol Drug Dev
; 2024 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38410874
3.
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis.
Clin Transl Sci
; 17(1): e13682, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38112262
4.
Efficacy and safety of upadacitinib for 16-week extended induction and 52-week maintenance therapy in patients with moderately to severely active ulcerative colitis.
Aliment Pharmacol Ther
; 59(3): 393-408, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38010661
5.
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study.
Lancet Gastroenterol Hepatol
; 8(11): 976-989, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37683686
6.
Observational data from the adalimumab post-marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysis.
United European Gastroenterol J
; 10(5): 485-495, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35560533
7.
Pharmacokinetics and distribution of linezolid in cerebrospinal fluid in children and adolescents.
Pediatr Infect Dis J
; 29(9): 827-30, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20442688
Resultados
1 -
7
de 7
1
Próxima >
>>